Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 1217-1221

  Kim, So H ^a   Shim, Hyun J ^b   Kim, Won B ^b   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Dong A Pharmaceutical Company   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 HYDROXYETHYL) 2 [2 (3 METHANESULFONYLAMINO 1 PROPENYL) 4 PYRROLIDINYLTHIO] 1 METHYL 1 CARBAPEN 2 EM 3 CARBOXYLIC ACID; CARBAPENEM; UNCLASSIFIED DRUG; URANYL NITRATE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; URINARY EXCRETION;

EID: 0031959802     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.1217     Document Type: Article

References (22)

1. Chiou, W. L. 1978. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokinet. Biopharm. 6:539-546.
2. Chiou, W. L. 1979. New calculation method for mean apparent drug volume of distribution and application to rationale dosage regimens. J. Pharm. Sci. 68:1067-1069.
3. Chiou, W. L. 1980. New calculation method of mean total body clearance of drugs and its application to dosage regimens. J. Pharm. Sci. 69:90-91.
4. Choi, S. H., G. W. Kim, J. Y. Kim, G. J. Lim, D. Y. Chung, W. B. Kim, and J. Yang. 1996. Interaction of DA-1131, a new carhapenem antibiotic, win bacterial β-lactamases, abstr. p. 237. In Abstracts of the Annual Meeting of the Korea Society of Applied Pharmacology, Seoul National University Seoul, Korea.
5. Danhof, M., M. Hisaoka, and G. Levy. 1984. Kinetics of drug action in disease states. II. Effect of experimental renal dysfunction on phenobarbital concentrations in rats at onset of loss of righting reflex. J. Pharmacol. Exp. Ther 230:627-631.
6. Eatman, F. B., W. A. Colburn, H. G. Boxenbaum, H. N. Posmanter, R. E. Weinfeld, R. Ronfeld, L. Weissman, J. D. Moore, M. Gibaldi, and S. A. Kaplan. 1977. Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. J. Pharmacokinet. Biopharm. 5:481-404
7. Engineer, M. S., D. W. Ho, and G. P. Bodey, Sr. 1981. Comparison of vancomycin disposition in rats with normal and abnormal renal functions. Antimicrob. Agents Chemother. 20:718-722.
8. Fruncillo, R. J., B. N. Swanson, R. Bernhard, C. Marchion, and R. K. Ferguson. 1986. Effect of renal failure or biliary stasis on the pharmacokinetics of amiodarone in the rat. J. Pharm. Sci. 75:150-154.
9. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
10. Kim, G. W., M. S. Chang, K. W. Lee, Y. S. Chong, and J. Yang. 1996. Comparative in vitro antibacterial activity of DA-1131, a new carbapenem antibiotic (I), abstr. p. 232. In Abstracts of the Annual Meeting of the Korea Society of Applied Pharmacology, Seoul National University, Seoul, Korea.
11. Kim, J. Y., G. W. Kim, S. H. Choi, J. S. We, H. S. Park, and J. Yang. 1996. Renal dehydropeptidase-I (DHP-I) stability and pharmacokinetics of DA-1131, a new carbapenem antibiotic, abstr. p. 238. In Abstracts of the Annual Meeting of the Korea Society of Applied Pharmacology, Seoul National University, Seoul, Korea.
12. Kim, O. N. 1991. Pharmacokinetics of theophylline in experimental acute renal failure rats (I). Yakhak Hoeji 35:38-44.
13. Kim, S. H., Y. M. Choi, and M. G. Lee. 1993. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J. Pharmacokinel. Biopharm. 21:1-17.
14. Kim, S. H., W. B. Kim, and M. G. Lee. 1995. Stability, tissue metabolism, tissue distribution, and blood partition of DA-1131, a new carbapenem. Res. Commun. Mol. Pathol. Pharmacol. 90:347-362.
15. Kim, S. H., J. W. Kwon, and M. G. Lee. Pharmacokinetics and tissue distribution of a new carbapenem, DA-1131, after intravenous administration to mice, rats, rabbits, and dogs. Biopharm. Drug Dispos., in press.
16. Kim, S. H., J. W. Kwon, J. Yang, and M. G. Lee. 1997. Determination of a new carbapenem derivative, DA-1131, in plasma and urine by high-performance liquid chromatography. J. Chromatogr. Ser. B 688:95-99.
17. Kim, Y. G., E. J. Yoon, W. H. Yoon, H. J. Shim, S. D. Lee, W. B. Kim, J. Yang, and M. G. Lee. 1996. Pharmacokinetics of DA-125, a new anthracycline, after intravenous administration to uranyl nitrate-induced acute renal failure rats or protein-calorie malnutrition rats. Biopharm. Drug Dispos. 17:183-195.
18. Lee, H. J., W. H. Paik, and M. G. Lee. 1996. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats. Res. Commun. Mol. Pathol. Pharmacol. 91:195-204.
19. Lee, Y.-H., M.-H. Lee, and C.-K. Shim. 1992. Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure. Pharm. Res. 9:1599-1606.
20. Park, J. M., C.-H. Moon, and M. G. Lee. 1996. Pharmacokinetic changes of methotrexate after intravenous administration to uranyl nitrate-induced acute renal failure rats. Res. Commun. Mol. Pathol. Pharmacol. 93:353-362.
21. Park, K. J., W. H. Yoon, S. H. Kim, W. G. Shin, and M. G. Lee. Pharmacokinetic and pharmacodynamic changes of azosemide after intravenous and oral administration of azosemide to uranyl nitrate-induced acute renal failure rats. Biopharm. Drug Dispos., in press.
22. Terao, N., and D. D. Shen. 1984. Pharmacokinetics of l-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats. J. Pharmacokinet. Biopharm. 12:479-493.